7
Clinical Trials associated with Fecal Microbiota Transplantation(Changzhou No.2 People's Hospital)Safety and efficacy of fecal microbiota transplantation in the treatment of diabetic nephropathy: a randomized controlled clinical trial
Start Date10 Aug 2024 |
Sponsor / Collaborator- |
Exploring the Application Value and Underlying Mechanism of Fecal Microbiota Transplantation in Early Acute Gastrointestinal Injury Following Cardiopulmonary Bypass Surgery
Start Date01 Aug 2024 |
Sponsor / Collaborator- |
Fecal Microbiota Transplantation Combined with Platinum-based Doublet Chemotherapy and Tislelizumab As First-line Treatment for Driver-gene Negative Advanced Non-small-cell Lung Cancer (NSCLC): Study Protocol for a Prospective, Multi-center, Single-arm Exploratory Trial
This study plans to reconstruct intestinal microecology through fecal microbiota transplantation (FMT), and combine with standard first-line therapy to enhance the anti-tumor immune effect at the same time, thereby extending the progression-free survival of patients and improving the prognosis of patients.
100 Clinical Results associated with Fecal Microbiota Transplantation(Changzhou No.2 People's Hospital)
100 Translational Medicine associated with Fecal Microbiota Transplantation(Changzhou No.2 People's Hospital)
100 Patents (Medical) associated with Fecal Microbiota Transplantation(Changzhou No.2 People's Hospital)
100 Deals associated with Fecal Microbiota Transplantation(Changzhou No.2 People's Hospital)